首页|利用光诱导电子转移机制构筑Ⅰ型聚集诱导发光光敏剂用于光动力治疗

利用光诱导电子转移机制构筑Ⅰ型聚集诱导发光光敏剂用于光动力治疗

扫码查看
原文链接
  • NETL
  • NSTL
  • 万方数据
光动力治疗(PDT)作为一种非侵入性抗癌方式，凭借其低毒、高时空选择性及操作简捷可控等优势受到越来越多的关注。光动力治疗主要依靠光敏剂在特定激发波长光源照射下产生活性氧(ROS)以消融癌细胞。然而，乏氧是实体肿瘤的固有属性，而传统的Ⅱ型光敏剂对氧气依赖度高，制约着PDT的治疗效果。因此，设计开发对氧气依赖度低的Ⅰ型光敏剂用于抗肿瘤具有重要研究意义。报道了一种通过引入光诱导电子转移(PET)机制制备高效Ⅰ型光敏剂的设计策略。通过在具有聚集诱导发光(AIE)活性的(Z)-2-(5-(4-(二乙氨基)-2-羟基亚苄基)-4-氧代-3-苯基噻唑烷-2-亚基)丙二腈(DR-OH)上引入4-硝基苄基，得到光敏剂DR-NO2，光激发后会发生PET过程，使得DR-NO2的荧光得到一定程度的淬灭，促进三线态产生，同时还促进分子内电荷分离和更有效的分子内电子转移，进而促进其Ⅰ型ROS尤其是超氧自由基的产生。此外，通过纳米工程制备得到DR-NO2纳米粒子具有较小的纳米尺寸、优秀的肿瘤细胞摄取能力以及进一步增强的Ⅰ型ROS产生能力，在光照下对MCF-7细胞展现出优秀的PDT杀伤能力。这种PET策略开发的Ⅰ型ROS的光敏剂在抗乏氧肿瘤PDT应用中具有巨大潜力。
Construction of Type Ⅰ Aggregation-Induced Emission Photosensitizers for Photodynamic Therapy via Photoinduced Electron Transfer Mechanism
Photodynamic therapy(PDT)as a non-invasive anticancer modality has received increasing attention due to its advantages of noninvasiveness,high temporospatial selectivity,simple and controllable operation,etc.PDT mainly relies on the generation of toxic reactive oxygen species(ROS)by photosensitizers(PSs)under the light irradiation to cause cancer cell apoptosis and death.However,solid tumors usually exhibit an inherent hypoxic microenvironment,which greatly limits the PDT efficacy of these high oxygen-dependent conventional type Ⅱ PSs.Therefore,it is of great importance to design and de-velop efficient type Ⅰ PSs that are less oxygen-dependent for the treatment of hypoxic tumors.Herein,a new strategy for the preparation of efficient type Ⅰ PSs by introducing the photoinduced electron transfer(PET)mechanism is reported.DR-NO2 is obtained by introducing 4-nitrobenzyl to(Z)-2-(5-(4-(diethylamino)-2-hydroxybenzylidene)-4-oxo-3-phenylthiazolidin-2-ylidene)malononitrile(DR-OH)with aggregation-induced emission(AIE)feature.The AIE feature ensures their high ROS generation efficiency in aggregate,and the PET process leads to fluorescence quenching of DR-NO2 to promote triplet state formation,which also promotes intramolecular charge separation and electron transfer that is conducive for type Ⅰ ROS partic-ularly superoxide radicals generation.In addition,DR-NO2 nanoparticles are prepared by nanoprecipitation to possess na-noscaled sizes,high cancer cell uptake,and excellent type Ⅰ ROS generation ability,which results in an excellent performance in PDT ablation of MCF-7 cancer cells.This PET strategy for the development of type Ⅰ PSs possesses great potential for PDT applications against hypoxic tumors.

photodynamic therapyaggregation-induced emissionphotoinduced electron transfertype Ⅰ photosensitizerhypoxic tumor microenvironment

贾涵羽、俞岳文、冯光雪、唐本忠

展开 >

华南理工大学材料科学与工程学院 发光材料与器件国家重点实验室 广东省分子聚集发光重点实验室 广州 510640

香港中文大学(深圳)理工学院 深圳分子聚集体科学与工程研究院 广东深圳 518172

光动力治疗 聚集诱导发光 光致电子转移 Ⅰ型光敏剂 乏氧肿瘤

广州市应用基础研究计划项目国家自然科学基金委青年科学基金广东省分子聚集发光重点实验室资助项目

2024A04J2466222050672023B1212060003

2024

10.6023/cjoc202403055

有机化学
中国化学会,中国科学院上海有机化学研究所

有机化学

CSTPCD北大核心
影响因子：1.09
ISSN：0253-2786
年,卷(期)：2024.44(8)